Deprescribing Strategies for Opioids and Benzodiazepines with Emphasis on Concurrent Use: A Scoping Review

While the Food and Drug Administration’s black-box warnings caution against concurrent opioid and benzodiazepine (OPI–BZD) use, there is little guidance on how to deprescribe these medications. This scoping review analyzes the available opioid and/or benzodiazepine deprescribing strategies from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yanning, Wilson, Debbie L., Fernandes, Deanna, Adkins, Lauren E., Bantad, Ashley, Copacia, Clint, Dharma, Nilay, Huang, Pei-Lin, Joseph, Amanda, Park, Tae Woo, Budd, Jeffrey, Meenrajan, Senthil, Orlando, Frank A., Pennington, John, Schmidt, Siegfried, Shorr, Ronald, Uphold, Constance R., Lo-Ciganic, Wei-Hsuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002935/
https://www.ncbi.nlm.nih.gov/pubmed/36902574
http://dx.doi.org/10.3390/jcm12051788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002935/
https://www.ncbi.nlm.nih.gov/pubmed/36902574
http://dx.doi.org/10.3390/jcm12051788

Ejemplares similares